GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Yselty (linzagolix) - Kissei, Syneos Health, Apotex

Orgovyx (relugolix) - Takeda, Sumitomo Pharma, Pfizer

Orilissa (elagolix) - AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/42360331

Fabio Barra; Francesca Olcese; Francesco Paolo Rosato; Irene Gazzo; Silvia Ottonello; Simone Ferrero; Umberto Perrone; Valerio Gaetano Vellone

Jun 27, 2026